期刊文献+

糖尿病足分离的铜绿假单胞菌对氨基糖苷类抗生素耐药机制探讨 被引量:1

Study on aminoglycoside antibiotics resistance of Pseudomonas aeruginosa isolated from diabetic foot infections
下载PDF
导出
摘要 目的分析糖尿病足溃疡感染(DFI)铜绿假单胞菌(PA)的临床特点及对氨基糖苷类抗生素(Am An)耐药的表型和基因型。方法采集本院209例DFI患者感染部位的细菌学报告及药敏结果,筛选出41株PA菌株,以聚合酶链反应(PCR)检测Am An修饰酶基因aac(3′)-Ⅱ、aac(6′)-Ⅰb、aac(6′)-Ⅱ、ant(2′′)-Ⅰ、ant(3′′)-Ⅰ及aac(3′)-Ⅰ,结合患者的临床资料和耐药报告,对耐药基因型及耐药表型进行相关分析。结果 DFI患者创面分离出的致病菌以革兰阳性(G+)菌为主(51.67%);PA的总检出率为19.62%,且是革兰阴性菌(G-)的首位致病菌(47.67%)。PA组患者溃疡面积≥4 cm2的比例高于非PA组和G+组,差异有统计学意义;与G+组相比,PA组患者缺血性溃疡、骨髓炎的发生率均较高,患者临床特点及溃疡深度评分(SAD评分)、超敏C反应蛋白增高,差异均有统计学意义。30株PA对Am An耐药(73.17%);耐药基因检出最多的为ant(3′′)-Ⅰ(65.85%),aac(3′)-Ⅰ未检出。结论 DFI患者PA检出率较高,且多见于溃疡面积较大、溃疡较深及缺血严重的患者中;PA对Am An的耐药现象较为严重;ant(3′′)-Ⅰ是检出的最常见的耐药基因。 Objective To investigate the clinical features, phenotypes and genotypes of Pseudomonas aeruginosa(PA)strains isolated from patients with diabetic foot infection(DFI) resisting to aminoglycosides antibiotics(Am An). Methods The clinical profiles of 209 DFI patients hospitalized in the Tianjin Metabolic Diseases Hospital were collected and ana-lyzed. Forty-one PA strains were identified, and their antibiotic resistance profiles were obtained. The DNAs of PA isolateswere extracted and applied to amplifications for several aminoglycosides modifying enzyme genes, including aac(3′)-Ⅰ, aac(3′)-Ⅱ, aac(6′)-Ⅰb, aac(6′)-Ⅱ, ant(2″)-Ⅰand ant(3″)-Ⅰ by PCR method. Combining with the clinical features and theantibiotic resistance profiles, the relationship between genotypes and phenotypes of the PA strains was analyzed. Results Gram positive bacteria(G+) were the majority of the pathogen with 51.67% detection rate. The total detection rate of PA was19.62%, listed as the top one pathogenic bacterium among gram negative bacteria(47.67%). There was significant differencein the ratio of ulcer area≥4 cm2 between PA group and non-PA group and G+group. There were significantly higher inci-dence rate of ischemic ulcer and osteomyelitis in PA group than those of G+group. There were higher clinical characteristicsand ulcer depth(SAD) score, and increased hypersensitive C-reactive protein in PA group than those of G+group. Therewere 30 strains of PA being resistant to Am An(73.17%). The predominant drug resistance gene to Am An was ant(3″)-Ⅰ(65.85%), and aac(3′)-Ⅰgene was not found from all PA isolates. Conclusion The detection rate of PA isolated from DFIpatients was higher, and patients were with the characteristics of larger, deeper and severe ischemia of ulcer area. The phe-nomenon of PA resistant to Am An was more serious, and ant(3″)-Ⅰgene identified from PA isolates was the most commonresistance gene identified to Am An.
出处 《天津医药》 CAS 2015年第7期768-772,共5页 Tianjin Medical Journal
关键词 糖尿病足 假单胞菌 铜绿 氨基糖苷类 微生物敏感性试验 DNA限制修饰酶类 diabetic foot pseudomonas aeruginosa aminoglycosides microbial sensitivity tests DNA restriction-modification enzymes
  • 相关文献

参考文献14

  • 1Futrega K, King M, Lott WB, e! al. Treating tile whole not the hole: necessary coupling of technologies for diabetic foot ulcer treahnent [J].Trends Mol Med, 2014, 20(3): 137-142. dui: lO. lOl6/j.mol- reed.2013.12.004.
  • 2Ramakant P, Verma AK, Misra R. el al. Changing microbiological profile of palhogtmic bacteria in diabetie foot infections: lime l~r a rethink on which empirical therapy to choose[J]?Diabelologia, 201 I, 54(1): 58-64. doi: 10.1007/s00125-010-1893-7.
  • 3Erlugrul BM, Oneul O, Tulek N, et al. A prospective, muhi-centerstudy: factors related to the management of diabetic foot infections [J]. Eur J Clin Microbiol Infect Dis, 2012, 31(9): 2345-2352. doi: 10.1007/s 10096-012-1574-1.
  • 4Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections[J]. Clin Infect Dis, 2012, 54 (12): e132-e173, doi: lO.1093/cid/cis346.
  • 5Fujitani S, Sun HY, Victor LY, et al. Pneumonia due to pseudomo- nas aeruginosa Part I: Epidemiology, clinical diagnosis, and source [J]. Chest, 2011,139(4): 909-919. doi: 10.1378/chest.10-0166.
  • 6Sugandhi P, Prasanth DA. Microbiological profile of bacterial patho- gens from diabetic foot infections in tertiary care hospitals, Salem [J]. Diabetes Metab Syndr, 2014, 8(3): 129-132. doi: 10.1016/j. dsx.2014.07.004.
  • 7Hatipoglu M, Mutluoglu M, Uzun G, et al. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review[J]. EurJ Clin Microbiol Infect Dis, 2014, 33(6): 871-878. doi: 10.1007/ s 10096-014-2047 -5.
  • 8申翔,丁群,孙茜,王鹏华,禇月颉,李代清.糖尿病足合并骨髓炎患者革兰阴性菌感染的临床特点及药敏分析[J].天津医药,2013,41(12):1165-1168. 被引量:2
  • 9屈艳,张崇,曹开源,苗霞,余广超.耐氨基糖苷类铜绿假单胞菌相关耐药基因的研究[J].中国抗生素杂志,2012,37(7):501-506. 被引量:5
  • 10蔡培泉,王春新,糜祖煌.铜绿假单胞菌氨基糖苷类耐药性及其修饰酶基因的研究[J].中华微生物学和免疫学杂志,2006,26(4):374-374. 被引量:9

二级参考文献47

  • 1许宏涛,张秀珍.医院感染铜绿假单胞菌多重耐药机制的研究[J].中国抗感染化疗杂志,2005,5(3):141-145. 被引量:58
  • 2杨维青,石磊,尹晓琳,李心晖,谢轶,程曦,曾蔚,殷长甫,贾文祥.不同地区铜绿假单胞菌第一类整合子和整合子相关基因盒的分布[J].中国抗生素杂志,2006,31(1):15-18. 被引量:17
  • 3Kayabas U, Bayraktar M, Otlu B, et al. An outbreak of Pseudomonas aeruginosa because of inadequate disinfection procedures in a urology unit: a pulsed-field gel electrophoresis-based epidemiologic study[J]. Am .1 Infect Control, 2008, 36(1): 33-38.
  • 4Doi Y, de Oliveira Garcia D, Adams J, et al. Coproduction of novel 16S rRNA methylase RmtD and metallo-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil[J]. Antimicrob Agents Chemother, 2007,12(4): 852-856.
  • 5Yamane K, Doi Y, Yokoyama K, et al. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates[J], Antimicrob Agents Chemother, 2004, 38(2) 2069-2074.
  • 6Shaw K J, Hare R S, Sabatelli F J, et al. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinicalisolates[J]. Antimicrob Agents Chemother, 1991, 35(3): 2253-2256.
  • 7Miller G H, Sabatelli F J, Hare R S, et al. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area[J]. Clin Infect Dis, 1997, 24(Suppl 1): $46- $51.
  • 8Wachino J, Yamane K, Shibayama K, et al. Novel plasmid- mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides[J]. Antimicrob Agents Chemother, 2006, 50(1): 178-184.
  • 9Gonzalez-Zorn B, Teshager T, Casas M, et al. ArmA and aminoglycoside resistance in Escherichia coli[J]. Emerg Infect Dis, 2005, 11(6): 954-956.
  • 10Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. Journal of Medical Microbiology, 2009, 58 ( Pt 9) : 1133-1148.

共引文献24

同被引文献14

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部